We have restudied two kindreds that formed the basis of the original report of autosomal recessive chronic granulomatous disease (CGD) associated with leukocyte glutathione peroxidase deficiency. Case 1 from the original study and the surviving brother of the originally reported case 2 both have severe CGD, with no detectable respiratory burst activity in purified intact neutrophils. However, their leukocytes exhibit normal glutathione peroxidase enzyme activity and gene expression.
Examination of phagocyte nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase components known to be defective in CGD reveals no detectable cytochrome b-nor any membrane activity in a cell-free NADPH oxidase assay system. Molecular analysis of the genes encoding cytochrome b5= subunits shows, in case 1, a C + T substitution at nucleotide 688 of the gene encoding the gp91-phox subunit of cytochrome bl %, resutting in a termination signal in place of . Levels of gp9l-phox mRNA are markedly decreased despite nor-EUTROPHILS and other professional phagocytes generate a "respiratory burst" of reactive derivatives of oxygen as an essential part of their microbicidal activity."' This family of antimicrobial oxidants is produced by a membrane-bound, multicomponent nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which catalyzes the one-electron reduction of molecular oxygen to the superoxide (0;) free radical. Superoxide is a reducing agent with mild direct bactericidal activity. However, it undergoes a dismutation reaction, either spontaneously or by the catalytic action of superoxide dismutase, to produce hydrogen peroxide and molecular oxygen. Peroxide not only possesses direct microbicidal activity but also serves as a source of even more potent reactive oxygen species3 and a wide variety of organic peroxides. It reacts with superoxide in an ironcatalyzed Haber-Weiss reaction to produce hydroxyl radical, the most reactive of the oxygen products, and possibly singlet oxygen, a high energy form of molecular oxygen. Peroxide also reacts with chloride ions in the presence of myeloperoxidase to generate hypochlorous acid: another potent microbicidal agent.
The reactive oxygen products are toxic not only to normal cells surrounding the activated neutrophil, but even to the neutrophil itself, which is subject to autooxidation by its own secretory p r o d u~t s .~,~ Cells are protected in part by enzymatic antioxidant defense pathways such as the glutathione cycle,' in which the initial detoxification reaction is catalyzed by the enzyme glutathione peroxidase (GSH-Px):
Human cellular GSH-Px (E.C. 1.1 1.1.9) is a selenium-containing8,9 enzyme that catalyzes the degradation of peroxides and hydroperoxides to their corresponding alcohols, using reduced glutathione (GSH) as a specific hydrogen donor?." At physiologic concentrations of peroxide, GSH-Px appears to be more important than catalase, which has a lower affinity mal levels of gene transcription, indicating a post-transcrip tional effect of the nonsense mutation on mRNA processing or stability. The X-linked form of CGD developed in this cytogenetically normal female due t o the uniform inactivation of the normal X chromosome in her granulocytes, indicated by the expression in her granulocyte mRNA of only one allele of a glucose-&phosphate dehydrogenase polymorphisms for which she is heterozygous in genomic DNA. Case 2 (of the present study) has distinct mutations in each allele of the p22-phox gene. Thus, the CGD phenotype in both kindreds now appears t o be caused not by leukocyte glutathione peroxidase deficiency, but rather by mutations of the same subunits of phagocyte NADPH oxidase that are involved in all other cases of cytochrome b-negative CGD. Glutathione peroxidase deficiency should no longer be considered a possible cause of the CGD phenotype. In 1968, when CGD was thought to be purely X-linked, two females with CGD were described" who thus constituted the first evidence of alternative, presumably autosomal recessive, forms of inheritance of the disease. They were subsequently reported to have a severe deficiency of leukocyte glutathione per0xidase.2~ Leukocyte G6PD and glutathione reductase activities were normal, as was NADH oxidase, a soluble enzyme believed at that time to be the respiratory burst oxidase. The membrane-bound NADPH oxidase (now known to be responsible for the respiratory burst) was not examined. The investigators hypothesized that the CGD phenotype in these two females was due to GSH-Px deficiency Because of the recent advances in our understanding of the molecular basis of CGD and of GSH-Px gene regulation, we restudied the cases that were originally reported to show an association of GSH-Px deficiency with CGD and that continue to be cited as examples of CGD due to defects in nonoxidase genes. CCD, henceforth referred to as case 2 of the present study (Fig 1) .
MATERIALS AND METHODS

CCD
His leukocytes, like those of his sister, showed no detectable reduction of nitroblue tetrazolium (NBT) dye after endotoxin stimulation, and they were severely deficient in killing of S aureus. In his first six months of life he had meningitis (considered aseptic), staphylococcal sepsis, interstitial pneumonia, and Pseudomonas osteomyelitis. He had no major problems until age 15 years, but since then he has experienced several episodes of pneumonia, recurrent sinusitis and soft tissue infections of the head and neck, acute cholecystitis requiring cholecystectomy, epididymitis and inguinal lymphadenitis from which cultures grew both Torula yeast and acid-fast bacilli, and hydronephrosis due to granulomas and strictures of both ureters requiring right nephrectomy and continued steroid treatment. There is no historical evidence for CCD among the 50 relatives of case 2 shown on the pedigree (Fig 1) . The patient's nephew (IV-6) died at age 3 months of sudden infant death syndrome. All relatives evaluated by laboratory testing showed normal endotoxin-stimulated NBT reduction (Fig 1, "N" ). This pattern provides strong evidence for classical genetic autosomal recessive inheritance.
Blood samples were obtained in accordance with human subjects procedures of the institutions at which the phlebotomies were performed.
Cell preparation. Neutrophils or mixed mononuclear cells were isolated from whole blood (anticoagulated with acid-citrate-dextrose) by dextran sedimentation, hypotonic lysis of erythrocytes, and Ficoll-Hypaque density gradient centrifugation (Pharmacia, Piscataway, NJ) as previously de~cribed?~.'~ Neutrophils used for cell-free activation experiments were obtained by leukapheresis, and the membrane and cytosol fractions were prepared as previously deCytochrome b. Spectrophotometric determinations of cytochrome bss8 contents of cell pellets (lo7 cells total) were performed by dithionite difference spectro~copy.'~ Immunoreactive gp91-phox and p22-phox quantitation was performed by Western blot, using previously reported antisera and meth~dology.'~~" Superoxide generation. Superoxide generation was determined histochemically by the reduction of NBT dye to blue formazan partic l e~.~' .~~ NBT tests were performed on glass slides, where adherent neutrophils were stimulated either by coating the slides with bacterial endotoxin3' or by addition of phorbol myristate acetate (PMA)." Neutrophils were examined by light microscopy for the presence of blue granules, and the percentage positive and intensity of staining were recorded for at least 200 cells in each sample.
Quantitative rates of superoxide production by intact neutrophils and by the cell-free NADPH oxidase system were measured as superoxide dismutase-inhibitable ferricytochrome c reduction, as previously de~cribed?~.'~.~ Intact neutrophils were activated by Ph4A (200 ng/mL) or chemotactic peptide formyl-methionyl-leucyl-phenylalanine (fMLP; mom); the cell-free system, by sodium dodecyl sulfate (SDS; 40 pmo/L). Cytosol activity in the cell-free system was determined by assaying varying amounts (allotted as cell equivalents) of partially purified cytosol from the patients' neutrophils in the presence of 6.25 X lo5 cell equivalents of deoxycholate-solubilized plasma membrane in each 150 pL reaction volume.
Membrane activity in the cell-free system was determined by assaying varying amounts of membrane from patients' neutrophils in the presence of 18 X l@ cell equivalents of cytosol. Normal control values were highly consistent between experiments, as previously reported.27 GSH-Px enzyme activity. GSH-Px activity was measured spectrophotometrically using the coupled peroxidase-reductase method of Be~tler.~' Both sample and reference cuvettes contained whole cells or neutrophil cytosol fraction, plus 0.05% Triton X-100, 0.2 mmol/L NADPH, 2 mmoVL GSH and 1 U/mL glutathione reductase. The oxidation of NADPH after addition of H,O, or t-butyl hydroperoxide to the sample cuvette was followed spectrophotometrically at 340 nm.
Northern blot. Total cell RNA was extracted from mixed mononuclear cells by the guanidine-HC1 method36 and analyzed by Northern blots performed according to standard p r o c e d~r e s .~~ Hybridization probes were full-length cDNAs for the human gp91-phod6 and p22-phox genes,30 and a 600-bp EcoRI fragment of human cellular GSH-Px cDNA containing most of the coding and 3'-untranslated regions. 38 Equal loading of lanes was demonstrated by examination of gels after ethidium bromide staining.
Nuclear run-on transcription assay. Incubation of nuclei and subsequent RNA isolation were performed with modifications of previously described procedure^.^' Nuclei were prepared from lymphoblastoid B cell lines derived from case 1 and a normal donor. These cell normally express all oxidase components and Serve as cellular and molecular models for CGD.Q"' Pilot experiments Single-strand conformation polymorphism (SSCP) analysis. Genomic DNA was extracted from peripheral blood37 and analyzed by SSCP as previously d e~c r i b e d~~,~ using two-stage nested primer polymerase chain reaction (PCR) utilizing outer 20 bp oligonucleotide primers with 0.1 pg of genomic DNA, then inner primers endlabelled with 32P with the first PCR products as template. The resultant labelled PCR products were visualized by polyacrylamide gel electrophoresis and autoradiography. SSCP analysis was performed on the 5' flanking region and all 13 exons of the gp91-phox gene.
DNA sequencing. Genomic DNA was isolated from peripheral blood leukocytes and PCR-amplified using standard methods.37 Dideoxy sequencing of the amplified segments was performed by standard methods.37
RESULTS
We first reconfirmed the diagnosis of CGD in both patients: case l from the original studyz3 and case 2, the brother of the originally reported case 2 (Fig 1) . Both patients have the cytochrome b-negative form of CGD, based on intact neutrophil studies ( Table 1 ) that exhibited no positively stained cells on PMA-or endotoxin-stimulated NBT slide tests, virtually no superoxide production in response to PMA or the chemotactic peptide fMLP, and undetectable levels of cytochrome by visible spectroscopy or in immunoblots for the gp91-phox and p22-phox subunits. Family studies of relatives of case 2 are essentially diagnostic of an autosomal recessive pattern of inheritance: CGD in a cytogenetically normal female and her brother, normal respiratory burst function32 in five siblings and in female members of the two preceding generations, and no history suggestive of CGD in any other members of the kindred over four generations. The respiratory burst oxidase can be activated in a cellfree system in which membranes and cytosol from unstimulated neutrophils are incubated in the presence of Mg++ and a lipid-perturbing agent such as arachidonic acid or SDS."
The cytosol fractions had normal activity (Fig 2A; data from case 2 not shown). In contrast, the membrane fractions from both cases were severely defective when mixed with normal cytosol (Fig 2B) . These findings indicate a profound lesion in the membrane-bound component of the oxidase and are typical of patients with either X-linked or autosomal recessive, cytochrome b-negative CGD. 28 We next measured levels of cellular GSH-Px enzymatic activity in each patient's neutrophils. Intact neutrophil homogenates (as well as purified neutrophil cytosol from case 1) were analyzed using two different GSH-Px substrates: Hz02 and t-butyl hydroperoxide. Under both assay conditions, each patient demonstrated normal levels of GSH-Px activity ( Table 2 ). As expected from the normal levels of GSH-Px enzyme activity, cases 1 and 2 also had normal levels of GSH-Px mRNA in their leukocytes, as shown by Northern blot analysis (Fig 3, top panel) .
All of the foregoing data suggest that the molecular lesion in each of the cases involves the membrane-bound cytochrome b component of the oxidase and not GSH-Px. We next sought to define precisely the responsible molecular defects. As case 1 is a female with cytochrome b-negative CGD, we predicted she would have a mutation involving the p22-phox subunit of cytochrome b, which is encoded by the CYBA locus on chromosome 16.17 However, case 1 has a normal level of p22-phox mRNA transcripts, but lacks instead message for the gp91-phox subunit, encoded by the CYBB locus on the X chromosome (Fig 3, lower panels) .
To determine whether a mutation in the gp91-phox gene could be responsible for its diminished expression, we screened the 5' (upstream) flanking region and all 13 exons of the gene by SSCP analysis of PCR-amplified genomic DNA. Single strand electrophoretic mobility of exon 7 in one allele of case 1 differed from her parents and of normal donors (data not shown), whereas the 5' flanking region and all other exons demonstrated normal mobility. Sequence analysis of exon 7 of the gp91-phox gene from case 1 showed a nonsense mutation consisting of a C -+ T substitution at nucleotide 688, resulting in a termination signal in place of arginine-226 (Fig 4) . Thus, case 1 has X-linked, not autosomal recessive, CGD. The sequence also shows the normal "C" base at that position, confirming the SSCP finding of heterozygosity for the mutation. Neither parent showed the same abnormalities in the SSCP (data not shown) or DNA sequence (Fig 4) ; therefore, the base change must represent a new mutation (localized by further studies, described below, to the paternal gp91-phox gene). The sequence abnormalities were not found in any of over 200 other X chromosomes studied; thus, as expected for a termination codon, the mutation did not appear to be a polymorphism of the gp9 1 -phox gene.
To determine the effect of this mutation on gp91-phox gene transcription, nuclear run-on assays were performed on nuclei from Epstein-Barr virus-transformed lymphoblastoid B cell lines derived from case 1 and a normal control donor. Nuclei from case 1 B cells demonstrated normal levels of transcription for both oxidase components, as well as for GSH-Px (Fig 5) . Ratios of transcription rates for case 1 relative to normal were 1.09 for gp91-phox, 1.19 for p22-phox, and 1.12 for GSH-Px (all normalized to the constitutively-expressed K a l tubulin control in the lowest lane). Thus, the decrease in gp91-phox mRNA appears to be a post-transcriptional event.
Possible explanations for the presence of an X-linked disease in a phenotypic female include a sex chromosome abnormality (ie, Turner Syndrome or XY female), an extremely skewed Lyon distribution of X-inactivation, or mutations in both X chromosome alleles. Multiple peripheral blood leukocyte cytogenetic analyses showed the normal 46,XX female karyotype. As reported in a preliminary communication:' examination of the nucleotide 13 1 1 polymorphism in the G6PD gene'" demonstrated both the 13 1 1 -C and I3 I 1 -T alleles in the patient's genomic DNA, but expression of only the 13 1 I -T allele in mRNA from her peripheral blood neutrophils. Both parents have normal NBT tests ( Table 1) and normal gp91-phox gene sequence at the arginine-226 codon, indicating that the patient's CGD allele arose as a new mutation. Her mother is homozygous for G6PD 131 I -C and her father hemizygous for G6P D I3 I 1 -T, so the CGD mutation appears to have occurred on the paternal X chromosome. The mutational event must have occurred within the father's germ line, since he does not demonstrate the defect in his hematopoietic cells.
RNA from leukocytes of case 2 contains normal levels of transcripts for both gp91-phox and p22-phox (Fig 3, lower  panels) as previously reported." by two distinct mutations in the two alleles for the p22-phox subunit. One allele contains a single nucleotide deletion (CCC + -CC) at nucleotide 272 (in the codon for proline-82). resulting in a frameshift of the open reading frame with eventual termination at 189 amino acids. The other allele carries a G + A mutation at nucleotide 297, which predicts the nonconservative missense substitution of a glutamine residue for arginine-90.
DISCUSSION
We have restudied two kindreds that were originally reported to have autosomal recessive CGD associated with GSH-Px deficiency."~?.' Case I from the original studies and the brother of the originally reported case 2 (Fig I ) both have CGD by current diagnostic criteria. However. their granulocytes exhibit normal cellular GSH-Px enzyme activity and gene expression. Examination of phagocyte NADPH oxidase components known to be defective in other cases of CGD reveals the absence of detectable cytochrome h,,, and of membrane activity in the cell-free oxidase assay. Molecular analysis of the genes encoding cytochrome h,,, subunits shows disabling mutations in the gp91-pho.r gene in case I and in the p22-pho.r gene in case 2. Thus, the CGD phenotype in both kindreds now appears to be caused not by GSHPx deficiency. but rather by mutations of the same subunits of phagocyte NADPH oxidase that are involved in all other cases of cytochrome h-negative CGD studied so far at the molecular The reason for the discrepancy between these results and those previously reported"," is not known. It is possible that the patients' medications or clinical conditions at the time of the previous study somehow affected measurements of GSH-Px activity. As GSH-Px is a selenoenzyme dependent upon availability of selenium for gene expression and enzyme activity.'X.'" deficiency of the trace element due to malnutrition. malabsorption, or inadequate intake could masquerade as primary GSH-Px deficiency."'.5' Selenium deticiency has been reported in patients with AIDS.'' possibly due in part to such consequences of impaired host defense. In addition. case I lives in South Dakota. a region of endemic selenium scarcity."
The acquisition of the X-linked form of CGD in case I. a cytogenetically normal female. occurred through the unfortunate coincidence of a new mutation in the gp9 1 -pho.r gene. along with uniform inactivation o f the normal X chromosome in her granulocytes. The development of a disease phenotype due to ;I lopsided distribution of X inactivation in carriers of an X-linked disorder has been reported for and other X-linked conditions such as hemophilia A and G6PD deficiency. determined, on the basis of the distribution of NBT-positive and -negative cells in CGD carriers, that the inactivation event takes place at time in embryogenesis when there are only about eight hematopoietic founder cells. Thus, the predicted probability of inactivation of the same X chromosome in all myeloid cells would be 1 in 256 (ie, 1:2*), a level that is low but would be expected to result in occasional patients such as ours within the population of CGD carriers.
Alternatively, the coincidental acquisition of a mutation inhibitory to myeloid development on the X chromosome bearing the normal gp91-phox gene would result in exclusive expression of the mutant gp91-phox by preventing maturation of those cells expressing the normal allele. This conjectural mutation would be the myeloid equivalent of the Xlinked immunodeficiencies in which obligate carriers express only the normal gene in their lymphocytes due to preferential survival of cells expressing the normal gene on the active X chromosome in lineages dependent on the gene product for development or function.60
The reason for the markedly decreased level of gp9 l-phox transcripts from a gene containing a nonsense mutation is unclear. In humans, nonsense mutations result in decreased levels of mRNA transcripts in some forms of ,Bo thalassemia and in deficiencies of triose phosphate isomerase and dihydrofolate These abnormal termination codons may interfere with nuclear mRNA processing6' or may diminish mRNA ~tability,6',~~ probably through decreased ribosomal protection from normal degradation pathways. In Succharomyces cerevisiue, premature termination of translation leads to mRNA degradation through the interaction of downstream sequence elements with at least one specific RNAbinding protein. 65 In summary, the reevaluation of both kindreds previously reported to have CGD associated with GSH-Px deficiencyz3 has demonstrated instead mutations of the same phagocyte oxidase subunits as found in other cases of cytochrome bnegative CGD,Z.47 along with normal GSH-Px enzyme activity and gene expression. Although acquired GSH-Px deficiency may affect phagocytic function, at least in animal should no longer be considered a possible cause of the CGD phenotype. mOdelS7.12.h6,67 and in congenital GSH-Px deficiency
